CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
DIA-ChIP aims to enhance molecular diagnostics for breast cancer through advanced techniques for high-throughput analysis of clinical samples. By focusing on DNA-protein interactions and utilizing archived materials, the project seeks to improve diagnostic accuracy and support personalized medicine while fostering coll…
DIA-ChIP seeks to develop state-of-the-art molecular techniques for the routine high-throughput analysis of clinical samples for advanced molecular diagnosis and biomedical research.
This will be achieved through a collaborative partnership between academic, SME and public health partners interacting through the IAPP, and the secondments and recruitments it supports.
New molecular diagnostics in clinical pathology need to be robust, cost effective and offer significant advantages over existing t…
SWANSEA UNIVERSITY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Belgium, Rixensart
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
United Kingdom, SWANSEA
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Fareham
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
